BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 38627587)

  • 1. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
    Oakley-Girvan I; Davis SW
    Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer biomarkers in exhaled breath.
    Amann A; Corradi M; Mazzone P; Mutti A
    Expert Rev Mol Diagn; 2011 Mar; 11(2):207-17. PubMed ID: 21405971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing diagnosis of benign lesions and lung cancer through ensemble text and breath analysis: a retrospective cohort study.
    Wang H; Wu Y; Sun M; Cui X
    Sci Rep; 2024 Apr; 14(1):8731. PubMed ID: 38627587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combined screening study for evaluating the potential of exhaled acetone, isoprene, and nitric oxide as biomarkers of lung cancer.
    Wang H; Wei X; Wu Y; Zhang B; Chen Q; Fu W; Sun M; Li H
    RSC Adv; 2023 Oct; 13(45):31835-31843. PubMed ID: 37908654
    [No Abstract]   [Full Text] [Related]  

  • 5. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
    Phillips M; Bauer TL; Cataneo RN; Lebauer C; Mundada M; Pass HI; Ramakrishna N; Rom WN; Vallières E
    PLoS One; 2015; 10(12):e0142484. PubMed ID: 26698306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of an Exhaled Breath Test Using High-Pressure Photon Ionization Time-of-Flight Mass Spectrometry to Detect Lung Cancer.
    Meng S; Li Q; Zhou Z; Li H; Liu X; Pan S; Li M; Wang L; Guo Y; Qiu M; Wang J
    JAMA Netw Open; 2021 Mar; 4(3):e213486. PubMed ID: 33783517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of volatile organic compounds in exhaled breath to screen lung cancer: a systematic review.
    Hua Q; Zhu Y; Liu H
    Future Oncol; 2018 Jul; 14(16):1647-1662. PubMed ID: 29939068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Invasive Lung Cancer Diagnostics through Metabolites in Exhaled Breath: Influence of the Disease Variability and Comorbidities.
    Temerdashev AZ; Gashimova EM; Porkhanov VA; Polyakov IS; Perunov DV; Dmitrieva EV
    Metabolites; 2023 Jan; 13(2):. PubMed ID: 36837822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Concept-Based Radiology Reports Classification Pipeline for Lung Carcinoma.
    Mithun S; Jha AK; Sherkhane UB; Jaiswar V; Purandare NC; Dekker A; Puts S; Bermejo I; Rangarajan V; Zegers CML; Wee L
    J Digit Imaging; 2023 Jun; 36(3):812-826. PubMed ID: 36788196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial intelligence in lung cancer diagnosis and prognosis: Current application and future perspective.
    Huang S; Yang J; Shen N; Xu Q; Zhao Q
    Semin Cancer Biol; 2023 Feb; 89():30-37. PubMed ID: 36682439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the landscape of lung cancer breath analysis: A scoping review (ELCABA).
    Schmidt F; Kohlbrenner D; Malesevic S; Huang A; Klein SD; Puhan MA; Kohler M
    Lung Cancer; 2023 Jan; 175():131-140. PubMed ID: 36529115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing Non-Small Cell Lung Cancer by Exhaled Breath Profiling Using an Electronic Nose: A Multicenter Validation Study.
    Kort S; Brusse-Keizer M; Schouwink H; Citgez E; de Jongh FH; van Putten JWG; van den Borne B; Kastelijn EA; Stolz D; Schuurbiers M; van den Heuvel MM; van Geffen WH; van der Palen J
    Chest; 2023 Mar; 163(3):697-706. PubMed ID: 36243060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung Cancer Nodules Detection via an Adaptive Boosting Algorithm Based on Self-Normalized Multiview Convolutional Neural Network.
    Khan A; Tariq I; Khan H; Khan SU; He N; Zhiyang L; Raza F
    J Oncol; 2022; 2022():5682451. PubMed ID: 36199795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer treatment and survivorship statistics, 2022.
    Miller KD; Nogueira L; Devasia T; Mariotto AB; Yabroff KR; Jemal A; Kramer J; Siegel RL
    CA Cancer J Clin; 2022 Sep; 72(5):409-436. PubMed ID: 35736631
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.